Item 8.01 Other Events

On November 15, 2012, Elite Pharmaceuticals, Inc. (the "Company") issued a press release to announce the initial shipment of Phendimetrazine tartrate 35 mg tablets under the previously announced manufacturing and supply agreement with Mikah Pharma, LLC ("Mikah"). Actavis, Inc. ("Actavis"), recently acquired by Watson Pharmaceuticals, Inc., will distribute the product as part of a distribution agreement between Mikah and Actavis.

A copy of the press release is being finished with this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.